EGFR AND HDAC DUAL INHIBITOR COMPOUNDS AND MEDICAL USE THEREOF

The present disclosure pertains to a compound useful for treating or palliating fibrosis, especially pulmonary fibrosis and a medical use thereof. La présente divulgation concerne un composé utile pour le traitement ou le soulagement de la fibrose, en particulier la fibrose pulmonaire et son utilisa...

Full description

Saved in:
Bibliographic Details
Main Authors KIM, Jae-Sun, LIM, Jee-Woong, SEO, Haeng Ran, KANG, Hee-geun, LEE, Yoon Jin, BAEK, Min Jung, KIM, Jihee, CHOI, Kwanghyun, SONG, Yeonhwa, LEE, Hae-June, RYU, Hyung-Chul, KIM, Sunjoo, NAM, Jae-Kyung, LEE, Ju Young
Format Patent
LanguageEnglish
French
Korean
Published 29.06.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present disclosure pertains to a compound useful for treating or palliating fibrosis, especially pulmonary fibrosis and a medical use thereof. La présente divulgation concerne un composé utile pour le traitement ou le soulagement de la fibrose, en particulier la fibrose pulmonaire et son utilisation médicale. 본 개시는 섬유증, 특히 폐 섬유증의 치료 또는 완화에 유용한 화합물 및 이의 의약 용도에 관한 것이다.
Bibliography:Application Number: WO2022KR20882